RIVERVIEW REGIONAL MEDICAL CENTER
1. Target Overview & Investment Thesis
RIVERVIEW REGIONAL MEDICAL CENTER is a 25-bed suburban community hospital in SMITH, TN with $24.6M in net patient revenue and a 1.4% operating margin. The hospital serves a payer mix of 43.9% Medicare, 10.1% Medicaid, and 46.0% commercial.
Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.4% to 8.7% (+736bps).
| Net Revenue HCRIS | $24.6M |
| Current EBITDA COMPUTED | $341K |
| Operating Margin COMPUTED | 1.4% |
| Occupancy HCRIS | 35.4% |
| Revenue / Bed COMPUTED | $986K |
| Net-to-Gross HCRIS | 19.7% |
| Distress Probability ML | 52.6% |
2. Market Context & Competitive Position
TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 1.4% places it above the state median. Among 55 size-comparable peers (12-50 beds), the median margin is -0.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-50), prioritizing same-state peers. 55 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| RIVERVIEW REGIONAL MEDICAL CEN (Target) | TN | 25 | $24.6M | 1.4% |
| BAPTIST MEM HOSPITAL TIPTON CO | TN | 48 | $179.0M | -5.8% |
| INDIAN PATH COMMUNITY HOSPITAL | TN | 35 | $142.8M | 12.0% |
| HENRY COUNTY MEDICAL CENTER | TN | 43 | $81.7M | -13.0% |
| THE CENTER FOR SPINAL SURGERY | TN | 23 | $78.7M | 39.3% |
| TRUSTPOINT HOSPITAL | TN | 18 | $50.8M | -0.8% |
| BAPTIST MEM HOSPITAL UNION CIT | TN | 43 | $50.5M | 5.1% |
| VANDERBILT BEDFORD COUNTY HOSP | TN | 24 | $49.5M | 1.9% |
| NEWPORT MEDICAL CENTER | TN | 32 | $47.8M | 11.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $518K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $493K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $488K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $300K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $16K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $341K |
| + RCM Uplift | +$1.8M |
| Pro Forma EBITDA | $2.2M |
| Current Margin | 1.4% |
| Pro Forma Margin | 8.7% |
| WC Released (1x) | $945K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $524K | $20.4M | 38.90x | 108.0% |
| Base (11x exit) | 10.0x | 11.0x | $524K | $22.6M | 43.12x | 112.3% |
| Bull Case | 9.0x | 11.0x | $472K | $28.8M | 60.96x | 127.5% |
| Bull (12x exit) | 9.0x | 12.0x | $472K | $31.5M | 66.79x | 131.7% |
| Bear Case | 11.0x | 10.0x | $577K | $11.1M | 19.34x | 80.8% |
| Bear (11x exit) | 11.0x | 11.0x | $577K | $12.5M | 21.59x | 84.9% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Elevated distress probability | Model estimates 52.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 55 hospitals with 12-50 beds
- Same-state prioritization (n=56)
- Comp margins: P25=-14.4% / P50=-0.8% / P75=9.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.